Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Wu, Rongqian ^a   Zhou, Mian ^a   Cui, Xiaoxuan ^a   Simms, H Hank ^a   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b N Shore Long Isl Jewish Res Inst ^*  (United States)

Author keywords

Aorta; Growth hormone secretagogue receptor; Gut; Polymicrobial sepsis; Vasoactive peptide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1A; HORMONE RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CECUM; CONTROLLED STUDY; HORMONE DETERMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SMALL INTESTINE; SMOOTH MUSCLE FIBER; VASODILATATION; WESTERN BLOTTING;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CECUM; IMMUNOHISTOCHEMISTRY; INTESTINES; LIGATION; LIPOPOLYSACCHARIDES; MALE; MYOCYTES, SMOOTH MUSCLE; PEPTIDE HORMONES; PUNCTURES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SEPSIS; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 4143111272     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00852.2003     Document Type: Article

References (43)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, and Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
2. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, and Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab 88: 701-704, 2003.
3. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, and Ghigo E. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23: 493-495, 2000.
4. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, and Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159: 1029-1037, 2002.
5. Basa NR, Wang L, Arteaga JR, Heber D, Livingston EH, and Tache Y. Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci Lett 343: 25-28, 2003.
6. Baue AE. Sepsis research: what did we do wrong? What would Semmelweis do today? Shock 16: 1-8, 2001.
7. Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, Warren VA, Howard AD, Van der Ploeg LH, and Heck JV. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43: 4370-4376, 2000.
8. Broglio F, Gottero C, Benso A, Prodam F, Casanueva FF, Dieguez C, Van Der Lely AJ, Deghenghi R, Arvat E, and Ghigo E. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Clin Endocrinol (Oxf) 58: 92-98, 2003.
9. Chang L, Du JB, Gao LR, Pang YZ, and Tang CS. Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin 24: 45-49, 2003.
10. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, and Opal S. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29: 880-886, 2001.
11. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, and Nakazato M. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275: 477-480, 2000.
12. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Dieguez C, and Tena-Sempere M. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 89: 400-409, 2004.
13. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87: 2988, 2002.
14. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, and Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48: 23-29, 1997.
15. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, and Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 86: 4284-4291, 2001.
16. Katugampola S and Davenport A. Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system. Trends Pharmacol Sci 24: 30-35, 2003.
17. Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K, and Rokutan K. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 48: 190-197, 2001.
18. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, and Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382-4389, 2001.
19. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
20. Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, and Wang P. Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 91: 70-76, 2000.
21. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, and Kangawa K. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280: R1483-R1487, 2001.
22. Nass R, Toogood AA, Hellmann P, Bissonette E, Gaylinn B, Clark R, and Thorner MO. Intracerebroventricular administration of the rat growth hormone (GH) receptor antagonist G118R stimulates GH secretion: evidence for the existence of short loop negative feedback of GH. J Neuroendocrinol 12: 1194-1199, 2000.
23. Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, and Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 85: 3803-3807, 2000.
24. Petersenn S. Structure and regulation of the growth hormone secretagogue receptor. Minerva Endocrinol 27: 243-256, 2002.
25. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50: 172-186, 1971.
26. Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, Kangawa K, and Sakai T. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 23: 531-536, 2002.
27. Sakata I, Tanaka T, Matsubara M, Yamazaki M, Tani S, Hayashi Y, Kangawa K, and Sakai T. Postnatal changes in ghrelin mRNA expression and in ghrelin-producing cells in the rat stomach. J Endocrinol 174: 463-471, 2002.
28. Shuto Y, Shibasaki T, Wada K, Parhar I, Kamegai J, Sugihara H, Oikawa S, and Wakabayashi I. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci 68: 991-996, 2001.
29. Tolle V, Bassant MH, Zizzari P, Poindessous-Jazat F, Tomasetto C, Epelbaum J, and Bluet-Pajot MT. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143: 1353-1361, 2002.
30. Tso JY, Sun XH, Kao TH, Reece KS, and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485-2502, 1985.
31. Wang G, Lee HM, Englander E, and Greeley GH Jr. Ghrelin-not just another stomach hormone. Regul Pept 105: 75-81, 2002.
32. Wang P, Ba ZF, and Chaudry IH. Nitric oxide: to block or enhance its production during sepsis? Arch Surg 129: 1137-1143, 1994.
33. Wang P, Ba ZF, and Chaudry IH. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol Regul Integr Comp Physiol 269: R988-R994, 1995.
34. Wang P, Ba ZF, Tait SM, Zhou M, and Chaudry IH. Alterations in circulating blood volume during polymicrobial sepsis. Circ Shock 40: 92-98, 1993.
35. Wang P and Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol Regul Integr Comp Physiol 270: R927-R938, 1996.
36. Wang P, Yoo P, Zhou M, Cioffi WG, Ba ZF, and Chaudry IH. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 85: 59-65, 1999.
37. Wang P, Zhou M, Rana MW, Ba ZF, and Chaudry IH. Microvascular hyperperfusion occurs in the liver, kidney, and spleen during early sepsis. Surg Forum 42: 43-45, 1991.
38. Wang P, Zhou M, Rana MW, Ba ZF, and Chaudry IH. Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol Gastrointest Liver Physiol 263: G38-G43, 1992.
39. Wiley KE and Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136: 1146-1152, 2002.
40. Wu R, Zhou M, Cui X, Simms HH, and Wang P. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. Int J Mol Med 12: 777-781, 2003.
41. Yang S, Chung CS, Ayala A, Chaudry IH, and Wang P. Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 17: 55-60, 2002.
42. Zhou M, Chaudry IH, and Wang P. The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am J Physiol Regul Integr Comp Physiol 281: R654-R660, 2001.
43. Zhou M, Wang P, and Chaudry IH. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1335: 182-190, 1997.